Vioquest Pharmaceuticals Inc VOQP
$0.00
Last Updated: Mar 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
V
Vioquest Pharmaceuticals Inc. Stock Analysis VOQP
United States Health Care Nano Cap VioQuest Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug therapies for the molecular basis of cancer and side effects of cancer treatment. The company is headquartered in Basking Ridge, New Jersey and currently employs 3 full-time employees. The Company’s lead compound under development is Xyfid (1% topical uracil) for the treatment and prevention of Hand-Foot Syndrome (HFS). In parallel, Xyfid is also being developed to treat dry skin conditions and manage the burning and itching associated with various diseases of the skin or dermatoses. In addition, VioQuest Pharmaceuticals is developing VQD-002 (triciribine phosphate monohydrate or TCN-P), a small molecule anticancer compound that inhibits activation of protein kinase B (PKB or AKT), a key component of a signaling pathway known to promote cancer cell growth and survival, as well as resistance to chemotherapy and radiotherapy. On July 16, 2007, the Company completed the sale of Chiral Quest, Inc. to Chiral Quest Acquisition Corp.
Vioquest Pharmaceuticals Inc (VOQP) Chart
Financial Metrics & Statements of Vioquest Pharmaceuticals Inc (VOQP)
FAQ's for Vioquest Pharmaceuticals Inc (VOQP)
- As of August 2026, Vioquest Pharmaceuticals Inc VOQP is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vioquest Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Vioquest Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Vioquest Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Vioquest Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Vioquest Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Vioquest Pharmaceuticals Inc (VOQP)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
